HighTide Therapeutics
HighTide Therapeutics develops oral therapies targeting metabolic and gastrointestinal diseases, with a focus on non-alcoholic steatohepatitis (NASH) and diabetes.
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Total funding raised: $107M
About
HighTide Therapeutics develops oral therapies targeting metabolic and gastrointestinal diseases, with a focus on non-alcoholic steatohepatitis (NASH) and diabetes.
MetabolicSmall Molecules
Funding History
1Total raised:$107M
Series B$107M